Sunday, November 08, 2009
Doing the business in Ireland
Ireland’s drug regulator has been accused of being too close to the pharmaceutical industry. An academic report has concluded that more than one-in-four senior personnel at the Irish Medicines Board (IMB) had “potential conflicts of interest”.
Subscribe to:
Post Comments (Atom)
Posts
0 comments:
Post a Comment